@article{article, title  = {{Early Changes in Patient-Relevant Endpoints in Three Tralokinumab Pivotal Phase 3 Trials (ECZTRA 1−3) in Adult Patients with Moderate-to-Severe Atopic Dermatitis}},

 publisher = {{National Society for Cutaneous Medicine}},

 url = {{}},

 year = {{2020}},

 month = {{10}},

 author = {{Silverberg JI and Cork M and Wollenberg A and Katoh N and Steffensen LA and Kurbasic A and Olsen CK and Kuznetsova A and Østerdal ML and Vilsbøll AW and Deleuran M}},

 doi = {{10.25251/skin.4.supp.98}},

 volume = {{4}},

 journal = {{SKIN The Journal of Cutaneous Medicine}},

 issue = {{6}},

 pages = {{s98-s98}},

 note = {{Accessed on 2024/12/22}}}